TY - JOUR AU - Travis, W. D. PY - 2010 DA - 2010// TI - Advances in neuroendocrine lung tumors JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq380 DO - 10.1093/annonc/mdq380 ID - Travis2010 ER - TY - JOUR AU - Rekhtman, N. PY - 2010 DA - 2010// TI - Neuroendocrine tumors of the lung: an update JO - Arch Pathol Lab Med VL - 134 ID - Rekhtman2010 ER - TY - JOUR AU - Bertino, E. M. AU - Confer, P. D. AU - Colonna, J. E. AU - Ross, P. AU - Otterson, G. A. PY - 2009 DA - 2009// TI - Pulmonary neuroendocrine/carcinoid tumors: a review article JO - Cancer VL - 115 UR - https://doi.org/10.1002/cncr.24498 DO - 10.1002/cncr.24498 ID - Bertino2009 ER - TY - JOUR AU - Metro, G. AU - Duranti, S. AU - Fischer, M. J. AU - Cappuzzo, F. AU - Crino, L. PY - 2012 DA - 2012// TI - Emerging drugs for small cell lung cancer - an update JO - Expert Opin Emerg Drugs VL - 17 UR - https://doi.org/10.1517/14728214.2012.656588 DO - 10.1517/14728214.2012.656588 ID - Metro2012 ER - TY - JOUR AU - Ohaegbulam, K. C. AU - Assal, A. AU - Lazar-Molnar, E. AU - Yao, Y. AU - Zang, X. PY - 2015 DA - 2015// TI - Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway JO - Trends Mol Med VL - 21 UR - https://doi.org/10.1016/j.molmed.2014.10.009 DO - 10.1016/j.molmed.2014.10.009 ID - Ohaegbulam2015 ER - TY - JOUR AU - Herbst, R. S. AU - Soria, J. C. AU - Kowanetz, M. PY - 2014 DA - 2014// TI - Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients JO - Nature VL - 515 UR - https://doi.org/10.1038/nature14011 DO - 10.1038/nature14011 ID - Herbst2014 ER - TY - JOUR AU - Khoja, L. AU - Kibiro, M. AU - Metser, U. PY - 2016 DA - 2016// TI - Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients JO - Br J Cancer VL - 115 UR - https://doi.org/10.1038/bjc.2016.308 DO - 10.1038/bjc.2016.308 ID - Khoja2016 ER - TY - JOUR AU - Hamid, O. AU - Robert, C. AU - Daud, A. PY - 2013 DA - 2013// TI - Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305133 DO - 10.1056/NEJMoa1305133 ID - Hamid2013 ER - TY - JOUR AU - Ramos-Esquivel, A. AU - van der Laat, A. AU - Rojas-Vigott, R. AU - Juarez, M. AU - Corrales-Rodriguez, L. PY - 2017 DA - 2017// TI - Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trials JO - ESMO Open VL - 2 UR - https://doi.org/10.1136/esmoopen-2017-000236 DO - 10.1136/esmoopen-2017-000236 ID - Ramos-Esquivel2017 ER - TY - JOUR AU - Powles, T. AU - Eder, J. P. AU - Fine, G. D. PY - 2014 DA - 2014// TI - MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13904 DO - 10.1038/nature13904 ID - Powles2014 ER - TY - JOUR AU - Domagala-Kulawik, J. PY - 2015 DA - 2015// TI - The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention JO - Transl Lung Cancer Res VL - 4 ID - Domagala-Kulawik2015 ER - TY - JOUR AU - Aerts, J. G. AU - Hegmans, J. P. PY - 2013 DA - 2013// TI - Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-3932 DO - 10.1158/0008-5472.CAN-12-3932 ID - Aerts2013 ER - TY - JOUR AU - Schultheis, A. M. AU - Scheel, A. H. AU - Ozretic, L. PY - 2015 DA - 2015// TI - PD-L1 expression in small cell neuroendocrine carcinomas JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2014.12.006 DO - 10.1016/j.ejca.2014.12.006 ID - Schultheis2015 ER - TY - STD TI - Thompson ED, Zahurak M, Murphy A, et al. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut. 2017;66:794–801. ID - ref14 ER - TY - JOUR AU - Vollbrecht, C. AU - Werner, R. AU - Walter, R. F. PY - 2015 DA - 2015// TI - Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.397 DO - 10.1038/bjc.2015.397 ID - Vollbrecht2015 ER - TY - JOUR AU - Lyford-Pike, S. AU - Peng, S. AU - Young, G. D. PY - 2013 DA - 2013// TI - Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-2384 DO - 10.1158/0008-5472.CAN-12-2384 ID - Lyford-Pike2013 ER - TY - JOUR AU - Taube, J. M. AU - Anders, R. A. AU - Young, G. D. PY - 2012 DA - 2012// TI - Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003689 DO - 10.1126/scitranslmed.3003689 ID - Taube2012 ER - TY - JOUR AU - Tumeh, P. C. AU - Harview, C. L. AU - Yearley, J. H. PY - 2014 DA - 2014// TI - PD-1 blockade induces responses by inhibiting adaptive immune resistance JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13954 DO - 10.1038/nature13954 ID - Tumeh2014 ER - TY - JOUR AU - Taube, J. M. AU - Young, G. D. AU - McMiller, T. L. PY - 2015 DA - 2015// TI - Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0244 DO - 10.1158/1078-0432.CCR-15-0244 ID - Taube2015 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - JOUR AU - Fan, Y. AU - Ma, K. AU - Wang, C. PY - 2016 DA - 2016// TI - Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors JO - Onco Targets Ther VL - 9 UR - https://doi.org/10.2147/OTT.S115054 DO - 10.2147/OTT.S115054 ID - Fan2016 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Teng, M. W. AU - Ngiow, S. F. AU - Ribas, A. AU - Smyth, M. J. PY - 2015 DA - 2015// TI - Classifying cancers based on T-cell infiltration and PD-L1 JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-15-0255 DO - 10.1158/0008-5472.CAN-15-0255 ID - Teng2015 ER - TY - JOUR AU - Twyman-Saint Victor, C. AU - Rech, A. J. AU - Maity, A. PY - 2015 DA - 2015// TI - Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer JO - Nature VL - 520 UR - https://doi.org/10.1038/nature14292 DO - 10.1038/nature14292 ID - Twyman-Saint Victor2015 ER - TY - JOUR AU - Dushyanthen, S. AU - Beavis, P. A. AU - Savas, P. PY - 2015 DA - 2015// TI - Relevance of tumor-infiltrating lymphocytes in breast cancer JO - BMC Med VL - 13 UR - https://doi.org/10.1186/s12916-015-0431-3 DO - 10.1186/s12916-015-0431-3 ID - Dushyanthen2015 ER - TY - JOUR AU - Yamaguchi, R. AU - Tanaka, M. AU - Yano, A. PY - 2012 DA - 2012// TI - Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer JO - Hum Pathol VL - 43 UR - https://doi.org/10.1016/j.humpath.2011.12.013 DO - 10.1016/j.humpath.2011.12.013 ID - Yamaguchi2012 ER -